Aigen Investment Management »

Lenz Therapeutics shares owned by Aigen Investment Management

Quarter-by-quarter ownership of Lenz Therapeutics (LENZ) shares owned by Aigen Investment Management from 13F filings

Historical chart of Aigen Investment Management investment in Lenz Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lenz Therapeutics held by Aigen Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lenz Therapeutics by Aigen Investment Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $114k 20k 5.68

More positions owned by Aigen Investment Management

Wells Fargo & Company (WFC)
Capital One Financial (COF)
CSX Corporation (CSX)
Abbott Laboratories (ABT)
Devon Energy Corporation (DVN)
PPL Corporation (PPL)
Gilead Sciences (GILD)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Trane Technologies SHS (TT)
Chubb (CB)
Lockheed Martin Corporation (LMT)
Vertex Pharmaceuticals Incorporated (VRTX)
Flex Ord (FLEX)
Lpl Financial Holdings (LPLA)
3M Company (MMM)

View all positions for Aigen Investment Management

Top funds holding Lenz Therapeutics

RA Capital Management
Falcon Edge Capital
FMR
Versant Venture Management
BlackRock
Squarepoint Ops
Standard Life Aberdeen
Millennium Management
Vanguard Capital Management
72 Investment Holdings
Blue Owl Capital Holdings
CAM Group Holding A/S
Morgan Stanley
Citadel Advisors
Geode Capital Management

View all funds holding Lenz Therapeutics